| Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers (NCT02964182) | M.D. Anderson Cancer Center | 2017-10-26 |
| Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer (NCT03279250) | M.D. Anderson Cancer Center | 2017-10-13 |
| Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma (NCT03096782) | M.D. Anderson Cancer Center | 2017-10-13 |
| 3D Printed Oral Stents for Patients With Head and Neck Cancer Receiving Radiation Therapy (NCT05126797) | M.D. Anderson Cancer Center | 2017-10-11 |
| Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma (NCT03019640) | M.D. Anderson Cancer Center | 2017-10-10 |
| Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery (NCT03307616) | M.D. Anderson Cancer Center | 2017-10-04 |
| Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery (NCT03214510) | M.D. Anderson Cancer Center | 2017-10-04 |
| Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC (NCT03263650) | M.D. Anderson Cancer Center | 2017-10-03 |
| Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma (NCT03283046) | M.D. Anderson Cancer Center | 2017-10-01 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer (NCT03222076) | M.D. Anderson Cancer Center | 2017-09-28 |
| Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia (NCT03214562) | M.D. Anderson Cancer Center | 2017-09-26 |
| Effect of Physician Attire on Patients' Preference of Physician (NCT03168763) | M.D. Anderson Cancer Center | 2017-09-25 |
| RCT of QPS vs General Information Sheet (NCT03287492) | M.D. Anderson Cancer Center | 2017-09-25 |
| Molecular Epidemiology of Biliary Tree Cancers (NCT05179486) | M.D. Anderson Cancer Center | 2017-09-25 |
| 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients (NCT03168737) | M.D. Anderson Cancer Center | 2017-09-22 |
| Investigation of Sugammadex in Outpatient Urological Procedures (NCT03138967) | M.D. Anderson Cancer Center | 2017-09-18 |
| Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study (NCT03408353) | M.D. Anderson Cancer Center | 2017-09-15 |
| Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma (NCT03068624) | M.D. Anderson Cancer Center | 2017-09-08 |
| A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma (NCT03008408) | M.D. Anderson Cancer Center | 2017-08-18 |
| Oral Supplementation to Enhance Recovery Pilot Study (NCT03204266) | M.D. Anderson Cancer Center | 2017-08-16 |
| Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia (NCT02730884) | M.D. Anderson Cancer Center | 2017-08-16 |
| Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer (NCT03202316) | M.D. Anderson Cancer Center | 2017-08-11 |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia (NCT03136146) | M.D. Anderson Cancer Center | 2017-08-09 |
| Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer (NCT03114462) | M.D. Anderson Cancer Center | 2017-08-09 |
| Mind-Body Intervention in Glioma Couples (NCT03244995) | M.D. Anderson Cancer Center | 2017-08-06 |
| Selumetinib and Olaparib in Solid Tumors (NCT03162627) | M.D. Anderson Cancer Center | 2017-08-04 |
| Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia (NCT03126864) | M.D. Anderson Cancer Center | 2017-08-04 |
| Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies (NCT03217747) | M.D. Anderson Cancer Center | 2017-08-02 |
| Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant (NCT03247088) | M.D. Anderson Cancer Center | 2017-07-30 |
| Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer (NCT03181100) | M.D. Anderson Cancer Center | 2017-07-27 |
| Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia (NCT03132454) | M.D. Anderson Cancer Center | 2017-07-25 |
| Investigating the Effect of Simulated Live Piano Music on Preoperative Cancer Patients, Health Care Providers and Hospital Volunteers Using Validated Questionnaires and Proteomic Analysis (NCT03239587) | M.D. Anderson Cancer Center | 2017-07-24 |
| Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss (NCT03131908) | M.D. Anderson Cancer Center | 2017-07-17 |
| Impact of a Systematic Social Work Driven Approach on Medical Power of Attorney Documentation, Knowledge, Attitudes, and Beliefs in Participants With Stage I-IV Gynecological Cancers (NCT03037346) | M.D. Anderson Cancer Center | 2017-07-17 |
| Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer (NCT03204812) | M.D. Anderson Cancer Center | 2017-07-14 |
| Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer (NCT03144778) | M.D. Anderson Cancer Center | 2017-07-12 |
| rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy (NCT03219502) | M.D. Anderson Cancer Center | 2017-07-10 |
| Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy (NCT03106610) | M.D. Anderson Cancer Center | 2017-07-07 |
| Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma (NCT03174197) | M.D. Anderson Cancer Center | 2017-06-30 |
| Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer (NCT03110978) | M.D. Anderson Cancer Center | 2017-06-26 |
| Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation (NCT03121534) | M.D. Anderson Cancer Center | 2017-06-22 |
| Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies (NCT03056339) | M.D. Anderson Cancer Center | 2017-06-21 |
| Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer (NCT03059940) | M.D. Anderson Cancer Center | 2017-06-16 |
| Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer (NCT03158129) | M.D. Anderson Cancer Center | 2017-06-16 |
| Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL (NCT03128879) | M.D. Anderson Cancer Center | 2017-06-16 |
| Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases (NCT03175432) | M.D. Anderson Cancer Center | 2017-06-15 |
| Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia (NCT02882282) | M.D. Anderson Cancer Center | 2017-06-14 |
| Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer (NCT03132467) | M.D. Anderson Cancer Center | 2017-06-13 |
| PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer (NCT03187951) | M.D. Anderson Cancer Center | 2017-06-13 |
| Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer (NCT03177460) | M.D. Anderson Cancer Center | 2017-06-07 |
| Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer (NCT03021486) | M.D. Anderson Cancer Center | 2017-06-05 |
| Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer (NCT03106077) | M.D. Anderson Cancer Center | 2017-06-05 |
| APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma (NCT02706353) | M.D. Anderson Cancer Center | 2017-06-02 |
| Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma (NCT02961816) | M.D. Anderson Cancer Center | 2017-06-01 |
| Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer (NCT03164460) | M.D. Anderson Cancer Center | 2017-05-22 |
| Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery (NCT03128866) | M.D. Anderson Cancer Center | 2017-05-19 |
| E-Health Support Program (PACK Health Program) in Supporting Patient Reported Symptoms in Newly Diagnosed Patients With Breast Cancer (NCT05549687) | M.D. Anderson Cancer Center | 2017-05-19 |
| Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03026062) | M.D. Anderson Cancer Center | 2017-05-18 |
| Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer (NCT03491176) | M.D. Anderson Cancer Center | 2017-05-18 |
| 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors (NCT03001349) | M.D. Anderson Cancer Center | 2017-05-16 |
| Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer (NCT02693717) | M.D. Anderson Cancer Center | 2017-05-09 |
| Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques (NCT03151564) | M.D. Anderson Cancer Center | 2017-05-09 |
| Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02923739) | M.D. Anderson Cancer Center | 2017-05-05 |
| Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer (NCT03040726) | M.D. Anderson Cancer Center | 2017-05-03 |
| Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma (NCT02959463) | M.D. Anderson Cancer Center | 2017-05-01 |
| Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer (NCT02918474) | M.D. Anderson Cancer Center | 2017-04-28 |
| Resting-State Functional MRI in Glioma Patients Before and After Surgery (NCT03964909) | M.D. Anderson Cancer Center | 2017-04-24 |
| Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer (NCT03015740) | M.D. Anderson Cancer Center | 2017-04-23 |
| Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer (NCT03141437) | M.D. Anderson Cancer Center | 2017-04-23 |
| Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT03023631) | M.D. Anderson Cancer Center | 2017-04-23 |
| Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible) (NCT02993068) | M.D. Anderson Cancer Center | 2017-04-18 |
| Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers (NCT03114501) | M.D. Anderson Cancer Center | 2017-04-11 |
| Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery (NCT03038152) | M.D. Anderson Cancer Center | 2017-04-11 |
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors (NCT03108131) | M.D. Anderson Cancer Center | 2017-04-07 |
| Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery (NCT03007030) | M.D. Anderson Cancer Center | 2017-04-05 |
| Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia (NCT03019939) | M.D. Anderson Cancer Center | 2017-03-28 |
| Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking (NCT03668769) | M.D. Anderson Cancer Center | 2017-03-27 |
| Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body (NCT03145077) | M.D. Anderson Cancer Center | 2017-03-21 |
| Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia (NCT02782403) | M.D. Anderson Cancer Center | 2017-03-20 |
| Development of a Patient Decision Aid for Women Considering Breast Reconstruction (NCT04817709) | M.D. Anderson Cancer Center | 2017-03-20 |
| Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC (NCT03066206) | M.D. Anderson Cancer Center | 2017-03-17 |
| Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer (NCT02940223) | M.D. Anderson Cancer Center | 2017-03-16 |
| Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT03041636) | M.D. Anderson Cancer Center | 2017-03-08 |
| Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery (NCT03012399) | M.D. Anderson Cancer Center | 2017-03-07 |
| Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery (NCT02812420) | M.D. Anderson Cancer Center | 2017-03-07 |
| Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer (NCT02530437) | M.D. Anderson Cancer Center | 2017-03-07 |
| Study of Ixazomib and Erlotinib in Solid Tumors (NCT02942095) | M.D. Anderson Cancer Center | 2017-03-06 |
| Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer (NCT03077841) | M.D. Anderson Cancer Center | 2017-03-06 |
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
| Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer (NCT02983578) | M.D. Anderson Cancer Center | 2017-03-02 |
| Phase II Study of TAK228 in Relapsed Lymphoma (NCT02727777) | M.D. Anderson Cancer Center | 2017-03-01 |
| Neoadjuvant Listeria or Daratumumab in Prostate Cancer (NCT03035357) | M.D. Anderson Cancer Center | 2017-03-01 |
| Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (NCT03099850) | M.D. Anderson Cancer Center | 2017-02-28 |
| Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies (NCT02804945) | M.D. Anderson Cancer Center | 2017-02-24 |
| Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer (NCT02912312) | M.D. Anderson Cancer Center | 2017-02-23 |
| Avelumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia (NCT02953561) | M.D. Anderson Cancer Center | 2017-02-20 |
| Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery (NCT02930902) | M.D. Anderson Cancer Center | 2017-02-20 |
| Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma (NCT02816021) | M.D. Anderson Cancer Center | 2017-02-14 |
| Colorectal Cancer (CRC) Surveillance Tool: Cognitive and Pilot Testing (NCT03180411) | M.D. Anderson Cancer Center | 2017-02-14 |
| Wearable Exercise Trackers in Cancer Rehabilitation (NCT03042884) | M.D. Anderson Cancer Center | 2017-02-13 |